Abstract
After a comment about new biologic treatments in psoriasis, we do a revision about efficiency with adalimumab: mechanism form, therapeutic indications, different guidelines and doses, and review of principals clinical trials about adalimumab in psoriasis, particularly CHAMPION and REVEAL.
MeSH terms
-
Adalimumab
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Humans
-
Psoriasis / drug therapy*
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Adalimumab